MoneyWorks4Me

Everest Organics informs about listing approval

12 Mar 2025 Evaluate
Everest Organics has informed that the Company has received listing approval from BSE vide their letter bearing no: LOD/PREF/VK/FIP/1940/2024-25 dated March 11, 2025 for listing of 17,10,526 Equity shares of Rs 10 each issued to non-promoters on preferential basis. The approval letter received from BSE is enclosed.

The above information is a part of company’s filings submitted to BSE.

Everest Organics Share Price

290.00 -7.90 (-2.65%)
25-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1917.00
Dr. Reddys Labs. 1191.00
Cipla 1420.00
Lupin 2175.00
Zydus Lifesciences 1130.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: